XML 20 R7.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash flows from operating activities    
Net loss including non-controlling interests $ (1,449) $ (5,826)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 656 395
Bad debt expense 75 51
Stock-based compensation 834 591
Gain on business divestitures, net (1,684) (127)
Gain from sale of investments (171) 0
Deferred income taxes (482) (272)
Loss from equity method investments, net 28 27
Unrealized loss on debt and equity securities, net 56 123
Impairment of debt and equity securities 0 1,690
Impairments of goodwill, long-lived assets and other assets 16 372
Unrealized foreign currency transactions 12 44
Other 50 (3)
Change in assets and liabilities, net of impact of business acquisitions and disposals:    
Accounts receivable (354) 380
Prepaid expenses and other assets (229) 159
Collateral held by insurer 860 259
Operating lease right-of-use assets 116 274
Accounts payable 71 (34)
Accrued insurance reserves 490 (16)
Accrued expenses and other liabilities 891 77
Operating lease liabilities (124) (104)
Net cash used in operating activities (338) (1,940)
Cash flows from investing activities    
Purchases of property and equipment (218) (493)
Purchases of marketable securities (1,113) (1,493)
Purchases of non-marketable equity securities (857) (10)
Purchase of notes receivable (242) (85)
Proceeds from maturities and sales of marketable securities 2,291 801
Proceeds from sale of non-marketable equity securities 500 0
Proceeds from sale of equity method investments and grant of related call option 800 0
Acquisition of businesses, net of cash acquired (111) (1,536)
Return of capital from equity method investee 0 91
Other investing activities 17 48
Net cash provided by (used in) investing activities 1,067 (2,677)
Cash flows from financing activities    
Issuance of senior notes, net of issuance costs 1,485 1,492
Principal repayment on Careem Notes (195) (891)
Principal payments on finance leases (166) (175)
Proceeds from the issuance of common stock under the Employee Stock Purchase Plan 67 82
Proceeds from sale of subsidiary preferred stock units 125 0
Other financing activities 50 (25)
Net cash provided by financing activities 1,366 483
Effect of exchange rate changes on cash and cash equivalents, and restricted cash and cash equivalents (45) (167)
Net increase (decrease) in cash and cash equivalents, and restricted cash and cash equivalents 2,050 (4,301)
Cash and cash equivalents, and restricted cash and cash equivalents    
Beginning of period 7,391 12,067
Reclassification from assets held for sale during the period 349 0
End of period 9,790 7,766
Reconciliation of cash and cash equivalents, and restricted cash and cash equivalents to the condensed consolidated balance sheets    
Cash and cash equivalents 6,482 6,154
Restricted cash and cash equivalents-current 414 218
Restricted cash and cash equivalents-non-current 2,894 1,394
Total cash and cash equivalents, and restricted cash and cash equivalents 9,790 7,766
Cash paid for:    
Interest, net of amount capitalized 319 296
Income taxes, net of refunds 71 68
Non-cash investing and financing activities:    
Finance lease obligations 115 190
Ownership interest received in exchange for divestitures 1,018 171
Conversion of convertible notes to common stock 232 0
Common stock issued in connection with acquisitions 967 96
Issuance of Careem Notes including the holdback amount $ 0 $ 1,634